UNIVERSITY OF NEW MEXICO
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1889-01-01
- Employees
- 6.7K
- Market Cap
- -
- Website
- https://www.unm.edu/
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
Not Applicable
Withdrawn
- Conditions
- Cervical CancerCervix
- First Posted Date
- 2006-03-01
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00298064
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
Terminated
- Conditions
- BreastCancer
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 22
- Registration Number
- NCT00277004
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Completed
- Conditions
- Corpus UteriLung Cancer
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 24
- Registration Number
- NCT00277082
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
Phase 1
Completed
- Conditions
- BreastCancer
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 33
- Registration Number
- NCT00277069
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Dysregulated Tyrosine Kinase Signaling in Leukemia
Terminated
- Conditions
- Leukemia
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 30
- Registration Number
- NCT00277056
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Phase 2
Completed
- Conditions
- Non-Hodgkin's LymphomaCancer
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 22
- Registration Number
- NCT00276003
- Locations
- ๐บ๐ธ
Lovelace Sandia Health Systems Dept of Hematology, Albuquerque, New Mexico, United States
๐บ๐ธUniversity of New Mexico, Albuquerque, New Mexico, United States
Exercise Induced Bronchospasm in Children
Phase 4
Completed
- Conditions
- Exercise Induced Bronchospasm
- Interventions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 13
- Registration Number
- NCT00273689
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
Phase 1
Completed
- Conditions
- Brain and Nervous SystemCancer
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 10
- Registration Number
- NCT00251797
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
Not Applicable
Terminated
- Conditions
- CancerOther Female Genital
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 15
- Registration Number
- NCT00250809
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
Phase 2
Completed
- Conditions
- LiverCancer
- Interventions
- Drug: Thalidomide, alpha interferonDrug: Thalidomide, interferon, Octreotide
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 12
- Registration Number
- NCT00250796
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
๐บ๐ธNew Mexico Cancer Care Associates, Santa Fe, New Mexico, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath